Robert Luther Huffines
Independent DirectorMr. Robert L. Huffines, also known as Robbie, serves as Board Member at Nextech Invest Ltd. He serves as an Independent Director at Becton, Dickinson and Company since December 01, 2025. He is Independent Director of Eikon Therapeutics, Inc. since December 1, 2023. He is an Independent Director at Insulet Corporation from October 31, 2025. He served as Global Chairman of Investment Banking at JPMorgan Chase & Co. Mr. Huffines served as Vice Chairman of Investment Banking at JPMorgan Chase & Co. since January 2011 and served as its Co-Managing Director of Health Care Investment Banking Group since July 7, 2006. He joined J.P. Morgan in 1991 in the Mergers and Acquisitions group, focusing on healthcare. in 2017 he was added to the Global Banking management team and named Co-Chair of the Global Strategic Advisory Council. Prior to joining J.P. Morgan, Mr. Huffines worked at Alex Brown & Sons, specializing in equity financing and advisory assignments for emerging growth companies. He was Co-Head, Global Healthcare Investing Banking, from 2002 to 2010 and positions in Healthcare Mergers and Acquisitions and Healthcare Industry Groups, from 1991 to 2002. Mr. Huffines earned his MBA at Darden, where he received the faculty award for academic excellence. His work includes being a member of the Center for the Business of Healthcare and Board of Visitors at UNC and serving as a board member of the Spence School, the Darden School at the University of Virginia and the Hastings Center, a leading independent, nonpartisan bioethics research institute. Mr. Huffines is also a member of the board of Nextech Invest Ltd. He holds a bachelor’s degree from the University of North Carolina, where he majored in English and economics.
Positions
- Company NameInsulet CorporationStock CodePODDPositionIndependent DirectorColleagues
- AAAshley A. McEvoyCEO, President & Director
- EHElizabeth H. WeathermanIndependent Chair
- FHFlavia H. PeaseExecutive VP & CFO
- EBEric BenjaminExecutive VP & COO
- JWJohn Wodick KapplesSenior VP & General Counsel
- PSPrem SinghSenior Vice President of Global Operations
- JHJessica HopfieldIndependent Director
- TCTimothy C. StonesiferIndependent Director
- Company NameEikon Therapeutics, Inc.Stock CodeEIKNPositionIndependent DirectorColleagues
- RMRoger M. PerlmutterChairman, President & CEO
- MAMichael A. KlobucharChief Operating Officer
- RDRoy D. BaynesExecutive VP & Chief Medical Officer
- RTRobert TjianCo-Founder & Member of Scientific Advisory Board
- EBEric BetzigCo-Founder & Member of Scientific Advisory Board
- KCKenneth C. FrazierIndependent Director
- RLRobert Luther HuffinesIndependent Director
